KRYS EPS Estimates
Krystal Biotech, Inc.
$330.69
+$9.53(+2.97%)
51
Overall
65
Value
30
Tech
60
Quality
Market Cap
$9.79B
Volume
276.38K
52W Range
$179.19 - $382.54
Target Price
$389.10
KRYS EPS estimates: the consensus estimate for Krystal Biotech, Inc.'s current fiscal year is $7.47 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KRYS EPS Estimates
- EPS estimate, current quarter
- $1.91
- EPS estimate, next quarter
- $2.05
- EPS estimate, current year
- $7.47
- EPS estimate, next year
- $9.16
- EPS growth, 3-year
- +48.72%
| Fiscal year | EPS |
|---|---|
| 2025 | $7.08 |
| 2024 | $3.12 |
| 2023 | $0.40 |
| 2022 | $-5.49 |
| 2021 | $-3.13 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRYS | $330.69 | +3.0% | 276.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |